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S U M M A R Y
Objective: To characterize Helicobacter pylori isolates from western Argentina using virulence markers
and antimicrobial susceptibility patterns in order to assess the association between virulent genotypes,
antimicrobial resistance, and disease. DNA ﬁngerprinting was also evaluated for the segregation of
virulent or resistant strain clusters.
Methods: Genotyping of 299 H. pylori isolates was performed by PCR using speciﬁc primers for the cagA,
vacA and iceA genes. Random ampliﬁcation of polymorphic DNA (RAPD)-PCR and rep-PCR genetic
clustering were assessed using ﬁve random primers and BOXA1R and ERIC primers, respectively.
Resistance to clarithromycin (Cla) and metronidazole (Mtz) was assessed by the agar dilution method.
Results: It was observed that 40.8% of the genotypeswere cagA-positive; 66.9%were vacA s1m1 genotype
and the iceA1 allele was found in 40.8%. A signiﬁcant correlation (p = 0.0000) was observed between cagA
positivity and vacA s1m1/iceA1 genotypes. Triple virulent genotypes were statistically associated with
peptic ulcer (PU) (p = 0.0001) and Cla resistance (p = 0.0000). RAPD ﬁngerprints obtained with AO2
primers identiﬁed clusters that were strongly associated with PU, virulence markers, and resistance to
Cla and Mtz.
Conclusions: The H. pylori isolates that harbored two or three virulence markers were more resistant to
Cla and Mtz. Combined analysis of virulent genotypes and resistance patterns may permit identiﬁcation
of high-risk patients to prevent PU later in life or to avoid antimicrobial treatment failure.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Helicobacter pylori is a curved Gram-negative bacterium
frequently present in the human stomach. Once the host has been
colonized, this microorganism persists for years or decades. This
microorganism has a worldwide distribution and is a major
etiological agent in the development of peptic ulcer (PU) and
gastric cancer.1
There are established genetic markers that contribute to the
pathogenicity of H. pylori, i.e., the cagA locus, vacA alleles and the
two allelic variants of the iceA gene. Strains expressing the CagA
protein, which is a part of a large pathogenecity island, have been
found to induce more severe inﬂammation, a higher degree of
gastric atrophy, and higher incidence of duodenal ulcer. These
effects could be explained by the increased density of H. pylori in
the antrum, which causes more profound inhibition of mucin
synthesis. Although the vacA gene is present in all H. pylori strains,
it is expressed in only 50–65% of them, thus inducing vacuolization* Corresponding author. Tel.: +54 02652 423789 ext. 127; fax: +54 02652 43403.
E-mail address: ticor@unsl.edu.ar (T.I. Cortin˜as).
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doi:10.1016/j.ijid.2009.11.022in gastric epithelial cells.2 Among the different allelic types of vacA,
vacAs1 and vacAs1m1 are toxic and strongly associated with
duodenal ulceration. The signal sequence of vacAs1, but not s2, is
closely associated with in vitro cytotoxin activity, PU, and with the
presence of the cagA gene.3,4 Them1 allele is associatedwith higher
levels of toxin activity and more severe gastric epithelial damage
than the m2 allele.3,4
The genetic organization of the iceA gene shows two distinct
iceA1 and iceA2 allelic variants. The iceA1 gene, whose expression is
induced by gastric epithelial cell contact, is associated with
virulence related to the production of interleukin-8.5–7 The iceA2
gene is completely unrelated to iceA1 in sequence, although the
iceA1 and iceA2 genes occupy the same locus in different strains.1,8
In a given community, apart from genetic diversity among
strains, there are indications of signiﬁcant geographical and ethnic
differences associated with these virulence markers. However, the
prediction of disease outcome based on combined cagA, vacA and
iceA status has provided contrasting results in several geographi-
cally distinct populations.2,6,9
The eradication of H. pylori can contribute to the treatment and
prevention of several pathologies associatedwith infection, such as
PU or gastric cancer.10 Treatment regimens combine two or moreses. Published by Elsevier Ltd. All rights reserved.
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tetracycline (Tet), and amoxicillin (Amx), with a proton pump
inhibitor (PPI). However antibiotic regimens against H. pylori are
frequently ineffective in developing countries due to strains with
increased resistance to these antimicrobial agents, which have
previously been used to treat respiratory or anaerobic and parasitic
infections. Resistance to Cla is associated with a greater risk for
failure with Cla-based treatments.11
Although there is no theoretical basis for predicting an
association between antibiotic resistance and virulence markers,
several studies have been carried out with the purpose of ﬁnding a
general association between them.12,13
The discriminatory ability of random ampliﬁcation of poly-
morphic DNA (RAPD)-PCR and rep-PCR ﬁngerprinting encourages
the use of these methods for the analysis of H. pylori diversity,
persistence, and virulence.14 It has been hypothesized that clonal
grouping by ﬁngerprinting may be associated with disease or
virulence factors, but studies using RAPD- and rep-PCR have
reached different conclusions.15
The aim of this study was to characterize H. pylori strains from
western Argentina using virulence markers and antimicrobial
susceptibility patterns, in order to determine possible associations
between virulent gene cagA, vacA and iceA alleles and clinical
outcome and antimicrobial resistance. Additionally RAPD-PCR and
rep-PCR genetic clustering of 34 isolates was evaluated to assess
their usefulness for the segregation of virulent or resistant strain
clusters.
Materials and methods
Biopsy samples, culture conditions, and identiﬁcation
Fresh antrum biopsy specimens were taken during endoscopy
from a total of 533 symptomatic patients of both sexes, inhabitants
of the city of San Luis (Argentina), aged between 21 and 80 years,
and with no previous record of antibiotic eradication therapy. H.
pylori strains were successfully isolated from 299 (56.1%).
Endoscopic diagnoses were as follows: 76 (25.4%) patients with
PU (34 with gastric ulcer and 42 with duodenal ulcer), 17 (5.7%)
patients with duodenitis, 10 (3.3%) patients with gastric cancer,
and 196 (65.6%) patients with chronic gastritis (CG). All sample
biopsies, one from each patient, were ﬁxed in formalin 10% v/v and
sent for histopathological evaluation. All endoscopic diagnoses
were conﬁrmed by histopathological analysis.
Cultures were prepared by smearing single biopsy specimens
on Petri plates containing Mueller–Hinton agar (MHA; Oxoid,
Basingstoke, Hampshire, UK) supplemented with 5–7% horse
blood and Dent supplement (H. pylori-selective supplement;
Oxoid). All cultures were incubated for 7–10 days at 37 8C in an
atmosphere of 5% O2, 10% CO2, 85% N2, and 98% humidity.H. pylori
colonies were presumptively identiﬁed by their typical morphol-
ogy. The isolates were conﬁrmed as H. pylori by Gram-stain
(negative and curved morphology) and catalase, oxidase, and
urease activities.
Antimicrobial susceptibility
Resistance to antimicrobial agents was assayed by the agar
dilution method according to the Clinical and Laboratory
Standards Institute (CLSI, 2000)16 using MHA supplemented
with 7% horse blood. Serial dilutions of Cla (Abbott Laboratories,
Argentina), Amx, Tet, and Mtz (Sigma Chemical Co., St. Louis,
MO, USA) ranging from 128 to 0.008 mg/l were used. The
bacteria were subcultured on MHA supplemented with 7% horse
blood under the microaerophilic conditions mentioned above, at
37 8C for 48 h. The bacterial suspension in Mueller–Hinton brothwas adjusted to a ﬁnal concentration of a McFarland 0.5
standard. One microliter of the adjusted inoculum was delivered
to the agar plates. The minimum inhibitory concentration (MIC)
of Cla, Amx, Tet, and Mtz was determined after 72 h of
incubation under a microaerobic atmosphere at 37 8C, and
recorded as the lowest concentration of drug inhibiting visible
growth. Resistance was deﬁned as a Cla MIC of 2 mg/l, Mtz MIC
of 8 mg/l, Tet MIC of >2 mg/l, and Amx MIC of >1 mg/l. The
reference strain H. pylori NCTC 11638 was used as control. All
tests were performed in duplicate.
Virulence markers
Genomic DNA was isolated from lysed H. pylori cells following
phenol–chloroform extraction and ethanol precipitation as
described previously.17 Virulence markers were determined by
PCR reactions carried out in a Thermal Cycler 2400 (Perkin Elmer
Applied Biosystems, Foster City, CA). The primers CAGA-F and
CAGA-R were used for detection of the cagA gene, which yields a
fragment of 349 bp. The analysis of the vacA s1/s2 vacA m1/m2
region was performed using primers VACA-F and VACA-R. For the
iceA1 allele analysis, primers iceA1F and iceA1R were employed.5
Clustering of antimicrobial resistance and virulence markers by
genetic techniques
Thirty-four H. pylori strains were genotyped by RAPD and rep-
PCR. A similar number of resistant and susceptible isolates were
employed. They were selected according to their antibiotic
resistance pattern: Cla-resistant (ClaR; 14 strains), Mtz-resistant
(MtzR; 10 strains, of which three were both ClaR and MtzR), Cla-
susceptible (ClaS; 20 strains), and Mtz-susceptible (MtzS; 24
strains). All strains were susceptible to Amx and Tet. Duplicates
from the antrum and corpus of two patients were included.
Endoscopic diagnoses were as follows: eight (23.5%) patients with
PU (two gastric ulcer and six duodenal ulcer), three (8.8%) patients
with duodenitis, and 23 (67.6%) patients with CG.
RAPD-PCR
The genomic DNA from bacterial samples was ampliﬁed with
ﬁve random primers: AO1, AO2, AO3, AO4, and AO5 (Promega,
Madison,WI, USA). The PCR reactionswere carried out as described
elsewhere.14 Each isolate was tested with the selected primers
under the same conditions at least three times.
Rep-PCR
The PCR reaction was performed using BOXA1R and ERIC
primers (Promega, Madison, WI, USA).14 Each isolate was tested
with the selected primers under the same conditions at least three
times.
Statistical analysis
Clustering analysis and the association between H. pylori
genotypes and clinical disease, as well as among virulencemarkers
and antibiotic resistance was evaluated using the Chi-square test
with Statix version 3.5 software. The signiﬁcance level was set at a
p-value of <0.05.
Results
A total of 299 (56.1%) H. pylori strains were isolated from 533
symptomatic patients. The isolates were characterized by viru-
lence markers and antimicrobial susceptibility.
Table 1
Association between virulent genotypes and gastric pathologies
Genotype Pathology
Chronic gastritis (n=196) Duodenitis (n=17) Peptic ulcer (n=76) Gastric cancer (n=10) Total (n=299)
cagA-pos 85 (43.4) 6 (35.3) 24 (31.6) 7 (70) 122 (40.8)
s1m1 143 (72.9) 0 50 (65.8) 7 (70) 200 (66.9)
iceA1 82 (41.8) 1 (5.9) 35 (46.1) 4 (40) 122 (40.8)
iceA1/iceA2 11 (5.6) 0 12 (15.8)c 3 (30) 26 (8.7)
Triple-virulenta 21 (10.5) 0 22 (30.6)d 1 (33.3) 44 (14.7)
Double-virulentb 52 (26.5) 0 41 (53.9)d 2 (20) 95 (31.8)
cagA-neg 111 (56.6) 11 (64.7) 52 (68.4) 3 (30) 177 (59.2)
s2m2 53 (27.0) 17 (100)e 26 (34.2) 3 (30) 99 (33.1)
iceA2 103 (52.5) 16 (94.1)c 29 (38.2) 3 (30) 151 (50.5)
Numbers in parentheses are percentages.
a cagA-pos/s1m1/iceA1 (n=44).
b cagA-pos/s1m1/iceA2 (n=62); cagA-neg/s1m1/iceA1 (n=26); cagA-pos/s2m2/iceA1 (n=7).
c Statistically signiﬁcant differences: cp=0.012: dp=0.001; ep=0.0009.
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The results of H. pylori strain genotyping are summarized in
Table 1. It was observed that 40.8% (122/299) of the genotypes
were cagA-positive and 59.2% (177/299) were cagA-negative. The
vacA s1m1 alleles were predominant, occurring in 66.9% (200/299),
while s2m2 was observed in 33.1% (99/299) of the isolates
(p = 0.001). No strains harboring s1m2 or s2m1 genotypes were
obtained in this study. AllH. pylori isolates possessed the iceA gene;
40.8% (122/299) were positive for the iceA1 allele, 50.5% (151/299)
were iceA2, and a PCR product of iceA1/iceA2 was obtained in 8.7%
(26/299) of the strains. The study of the association of the main
virulence genes showed 44 triple-positive (cagA-positive/s1m1/
iceA1) and 95 double-positive (cagA-positive/s1m1; cagA-positive/
iceA1 or s1m1/iceA1) strains.
Table 2 shows the distribution of cag status and the vacA and iceA
allelic combinations. A statistically signiﬁcant correlation was
observed between cagA-positive status and s1m1 (p = 0.0000),while
most s2m2 strains carried a cagA-negative (p = 0.0000) genotype. A
signiﬁcant association was also observed between cagA-negative
status and iceA1/iceA2 (p = 0.0006). Statistical analysis showed a
signiﬁcant association between virulent gene cagA-positive and
s1m1/iceA1 genotypes (p = 0.0000), while cagA-negativewas associ-
ated with s2m2/iceA1 and s2m2/iceA1/iceA2 (p = 0.0000).
Association between genotypes and gastric pathologies
The association between virulence markers and pathologies is
shown in Table 1. A signiﬁcant association between PU and iceA1/Table 2
Association between cagA status and vacA and iceA subtypes
Genotype cagA status
cagA-pos (n=122) cagA-neg (n=177)
vacA
s1m1 106 (86.9)a 94 (53.1)
s2m2 16 (13.1) 83 (46.9)a
iceA
iceA1 51 (41.8) 71 (40.1)
iceA2 71 (58.2) 80 (45.2)
Mixed infection iceA1/iceA2 0 26 (14.7)b
Genotype combinations
s1m1/iceA1 44 (36.1)c 26 (14.7)
s2m2/iceA2 9 (7.4) 19 (10.7)
s1m1/iceA2 62 (50.8) 61 (34.5)
s2m2/iceA1 7 (5.7) 45 (25.4)c
s1m1/iceA1/iceA2 0 7 (4.0)
s2m2/iceA1/iceA2 0 19 (10.7)c
Numbers in parentheses are percentages.
Statistically signiﬁcant differences: ap=0.0000; bp=0.0006; cp=0.0000.iceA2 (p = 0.0122) was observed. On the other hand, no statistical
correlation was found between this pathology and iceA1 or cagA
status (p = 0.0579 and p = 0.259 respectively), but an association
between PU and iceA1may be assumed as a clear tendency. Of the
patients with duodenitis, 64.7% were cagA-negative, and the s2m2
(p = 0.0009) and iceA2 (p = 0.012) genotypes were strongly
associated with this pathology. Most of the isolates characterized
came from patients suffering from CG. In this group, the most
abundant genotype was s1m1 (72.9%), followed by the cagA-
negative (56.6%) and iceA2 (52.5%) genotypes. For this pathology,
no signiﬁcant association with virulence markers was observed.
Double- and triple-positive virulent strains were signiﬁcantly
associated with PU (p = 0.001).
Antimicrobial susceptibility
The antimicrobial susceptibility of the 299 isolates is shown in
Table 3; MIC50 and MIC90 values are shown. All strains were
sensitive to Amx and Tet, while 83 (27.8%) strains were ClaR and
113 (37.8%) were MtzR. Only three strains were both ClaR and
MtzR.Correlation of virulence markers with antimicrobial suscept-
ibility
The distribution of virulence markers by antimicrobial suscept-
ibility pattern is shown in Table 4. The combined genotype cagA-
positive, vacA s1m1, iceA1 was predominant in ClaR (p = 0.0000)
and MtzR (p = 0.0000) strains. Also, a signiﬁcant association was
observed between the combined genotype cagA-negative, vacA
s1m1, iceA1 (p = 0.0000) and ClaR.
Analysis of RAPD ﬁngerprinting
Only AO2 and AO3 RAPD primers generated reproducible RAPD
ﬁngerprints. They were able to discriminate 34 different proﬁles
with 100% of typeability. Duplicate isolates coming from the same
patients were not discriminated by any of the genotyping
techniques assayed. The number and size of bands obtained with
RAPD for the AO2 primer varied from four to 12 and 140 to 3000 bp,
respectively. The segregation of PU was signiﬁcant (p = 0.03) in
cluster III. The dendrograms based on the RAPD proﬁles obtained
with the AO2 primer, including virulence markers, antimicrobial
susceptibilities, and pathology, are summarized in Figure 1. It was
determined whether the speciﬁc virulence markers and antimi-
crobial susceptibilities were associated with the RAPD cluster.
Isolates containing two or three combined virulence markers (9/
16; 56.3%) were included in cluster III, whereas isolates that
harbored no or only one virulence marker (15/18; 83.3%) were
placed in cluster II (p = 0.0007). There were also signiﬁcant
differences (p = 0.0000) in the segregation of susceptible and
resistant strains. Cluster III constituted 13/24 (54.2%) ClaR, MtzR or
Table 3
MICs of drugs and percentages of resistance among strains
Drugs MIC (mg/l) % Resistance
MIC50 MIC90 Range
Clarithromycin 8 32 0.008–128 27.8 (n=83)
Metronidazole 16 64 0.008–128 37.8 (n=113)
Amoxicillin 0.032 0.5 0.008–128 0
Tetracycline 0.016 0.25 0.008–128 0
MIC, minimum inhibitory concentration.
Numbers in parentheses are Helicobacter pylori isolates.
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susceptible strains.
With the AO3 primer, well-resolved patterns of seven to 13
fragments of 150 to 2000 bp were obtained. Neither the segrega-
tion of PU isolates nor the combined virulence markers were
signiﬁcant with this primer. In contrast, signiﬁcant differences
were observed in the segregation of susceptible and resistant
strains (p = 0.032). Cluster II constituted 16/24 (66.7%) ClaR, MtzR
or ClaR/MtzR strains, and cluster I grouped 24/44 (54.5%) of
susceptible strains with the exception of three ClaR strains
(MIC = 2 mg/l).
Analysis of rep-PCR ﬁngerprints
Thirty-one different BOX A1R proﬁles and 33 ERIC proﬁles were
obtained with 100% of typeability. The BOX A1R patterns consisted
of 7–14 bands with sizes ranging from 150 to 4000 bp. The
dendrogram based on rep ﬁngerprints obtained with the BOX A1R
primer, including virulencemarkers, antimicrobial susceptibilities,
and pathology, is summarized in Figure 2. A distinct pathological
cluster that was segregated with combined virulence markers and
ClaR andMtzR strains was observed with this primer. Isolates with
two or three combined virulence markers (9/17; 52.9%) were
included in cluster III, while isolates that harbored no or only one
virulence marker (11/17; 64.7%) were placed in cluster II
(p = 0.0008). There were also signiﬁcant differences (p = 0.0000)
in the segregation of susceptible and resistant strains. Cluster III
constituted 12/24 (50%) ClaR, MtzR or ClaR/MtzR strains, and
cluster II grouped 19/44 (43.2%) of susceptible strains.
The ERIC patterns consisted of approximately 7–13 bands per
isolate. The molecular sizes of the fragments ranged from 50 to
5000 bp. With this primer, isolates with two or three combined
virulence markers (7/17; 41.2%) were included in cluster III, while
isolates that harbored no or only one virulence marker (11/17;
64.7%) were placed in cluster II (p = 0.05).Table 4
Distribution of virulence markers of Helicobacter pylori isolates and antimicrobial susce
Genotypes Antimicrobial susceptibility patte
ClaS
cagA-pos s1m1 iceA1 10 (3.8)
cagA-pos s1m1 iceA2 58 (29.9)
cagA-pos s2m2 iceA1 4 (0.54)
cagA-pos s2m2 iceA2 6 (1.08)
cagA-neg s2m2 iceA2 15 (6.52)
cagA-neg s1m1 iceA1 7 (2.17)
cagA-neg s2m2 iceA1 34 (16.8)
cagA-neg s1m1 iceA2 57 (28.8)
cagA-neg s1m1 iceA1/iceA2 6 (1.6)
cagA-neg s2m2 iceA1/iceA2 19 (8.7)
Total 216
ClaS, clarithromycin-sensitive; ClaR, clarithromycin-resistant; MtzS, metronidazole-sen
a Three strains ClaR/MtzR.
Numbers in parentheses are percentages.Discussion
Many studies have mentioned the occurrence of bio-geogra-
phical variations in virulence factors and resistance rates of H.
pylori strains that may vary from one region to another, even in the
same country.18,19
The combination of the distinct cagA, vacA, and iceA genotypes
illustrates the mosaic composition of the H. pylori genome; strains
that are typed as cagA-positive/vacA s1m1/iceA1 can be considered
themost pathogenic and are found predominantly in patients with
ulcer disease. In contrast, strains typed as cagA-negative/vacA
s2m2/iceA2 appear to be the least pathogenic and do not occur in
PU patients.12,20
In this study it was found that 40.8% of the H. pylori strains were
cagA-positive, which is slightly higher than the result obtained in a
previous study in the same population21 and similar to the value
reported in a study from Chile (38%),22 but lower than reports from
eastern Argentina (77%)9 and Brazil (75.3%).23 A signiﬁcant
correlation was observed between cagA positivity and vacA s1m1.
This double virulence genotype is commonly linked to increased H.
pylori virulence.24 On the other hand, cagA-negative status was
signiﬁcantly associated with the less virulent vacA s2m2 genotype
(Table 2). It has been reported that individuals colonizedwith cagA-
positive H. pylori strains are at increased risk of developing peptic
ulceration.5,12 In this study, however, no correlation was observed
between cagA status and PU, probably due to the low incidence of
cagA-positive strains circulating in this geographical region.
The prevalence of vacA s1m1 alleles was signiﬁcantly higher
than that of s2m2 (p = 0.001). Similar prevalence of this genotype
has been observed in eastern Argentina9,21 and other Latin-
American countries, namely, Peru, Brazil, Costa Rica, and
Colombia5 andMexico,25 where s1m1was predominant in infected
patients. However, the types of signal sequences and media region
genotypes seem to vary with the geographical region. High rates of
vacA s1 genotype have been obtained in Argentina (74% and 75%),
Cuba (73.8%), and Brazil (62%).9,12,21,24 In the H. pylori isolates
analyzed here, no mixed vacA genotypes were observed as was
found in a previous study in western Argentina.21 In Latin-
American countries mixed vacA alleles have been detected at low
rates, ranging from 0.8%24 to 32%,12 in contrast with other
geographical regions, where mixed vacA are predominant, for
instance Pakistan with 63.6% and Turkey with 48.4%.26,27 Probably,
a much larger number of H. pylori isolates should be analyzed in
order to determine the presence of mixed vacA genotypes in the
western Argentinean population.
No correlation was found between vacA s1m1 strains and any of
the gastric pathologies, but a signiﬁcant association between vacAptibility pattern
rn
ClaR MtzS MtzR
34 (53.4)a 21 (11.8) 45 (47.2)a
4 (1.7) 9 (3.9) 22 (21.3)
3 10 (4.6) 3
3 8 (3.3) 3
4 (1.7) 29 (15.0) 21 (20.2)
19 (27.6) 23 (13.1) 11 (9.0)
11 (13.8) 6 (2.0) 2
4 (1.7) 55 (33.9) 5 (2.2)
1 7 (2.6) 1
0 18 (9.8) 0
83 186 113
sitive; MtzR, metronidazole-resistant.
Figure 1. Dendrogram of Helicobacter pylori strain AO2-PCR DNA ﬁngerprints. Three separate clusters (I, II, and III) at a genetic distance of approximately 57% are indicated.
Cluster III consists of 13 isolates from eight patients suffering from chronic gastritis (CG) and ﬁve patients with peptic ulcer (PU). The segregation of PU was signiﬁcant
(p = 0.03) in cluster III. There were signiﬁcant differences in the segregation of combined virulence markers (p = 0.0007) and in the segregation of susceptible and resistant
stains (p = 0.0000). Fingerprint analyses were carried out using SYSTAT software version 5.0 (Systac Inc., Melbourne, FL), and the matrix of the Ssm correlation coefﬁcients
were clustered by the unweighted paired group mean average method (UPGMA). The similarity between all ﬁngerprints obtained for each method is expressed as a Dice
coefﬁcient.
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consistent with the fact that less virulent vacA s2m2 genotypes are
associatedwith lower gastric epithelial damage, because very little
or no toxin is produced. However, in order to conﬁrm this
association, further studies are required with more patients
suffering this less severe pathology.
The prevalence of iceA2was higher than that of the iceA1 allele;
however, no statistically signiﬁcant difference was obtained.Similar frequencies of occurrence of the iceA1 and iceA2 alleles
were reported by Leanza et al. in 2004 in Argentina.9 Similarly, no
statistically signiﬁcant difference between iceA2 (44.9%) and iceA1
(30.8%) has been reported in Colombia. Our results contrast with
the reports of high prevalence of iceA1 alleles in the USA (78.6%)
and Brazil (74.2%).6,12 The rate of detection of isolates with both
iceA1/iceA2 alleles, which may be considered as mixed H. pylori
infections, was 8.7% (26/299) (Table 1). In this work, the iceA1/
Figure 2. Dendrogram of Helicobacter pylori strain BOX A1R DNA ﬁngerprints. Three separate clusters (I, II, and III) at a genetic distance of approximately 63% are indicated.
Cluster III consists of 15 isolates from 11 patients suffering chronic gastritis (CG), three patients with peptic ulcer (PU), and one patient with duodenitis. The segregation of PU
was signiﬁcant (p = 0.03) in cluster III. There were signiﬁcant differences in the segregation of combined virulence markers (p = 0.0008) and susceptible and resistant strains
(p = 0.0000).
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(p = 0.0006).
The number of mixed infections based on the iceA1/iceA2
genotype obtained in this study was similar to that obtained in
Brazil (7.74%),28 but higher than the number reported in a previous
study in eastern Argentina (2.3%).9 Mixed infection with two or
more H. pylori strains colonizing the same patient possibly
represents a stable association during longtime colonization.13
Also, it could be explained by the genetic rearrangement of a
founding cell and its capacity to lose and acquire exogenous DNA
during persistent colonization, resulting in a diversity of H. pylori
lines following bacterial adjustment to changing host conditions.29
The different rates of multiple infections reported from the
USA (4.3%), Japan (17%), Korea (20%), and Colombia (22%)6 could
reﬂect the ability of the genetic techniques used to detect
speciﬁc polymorphic loci and the number of biopsy samples
analyzed from a single patient, rather than real differences
between populations.
More recently, besides the genetic characterization of the
strains, host susceptibility factors have been taken into account to
understand the complex host–pathogen relationship that deter-
mines the natural history of H. pylori infection. Among them is the
association between genetic polymorphisms in pro-inﬂammatory
interleukin, which varies among individuals within the same
populations.30 Also the secretor status of the host has been studied
in different populations.31 In order to match host receptors and
thereby stabilize microbial colonization, H. pylori developed the
BabA and SabA adhesins, which bind to the host fucosylated blood
group ABO antigens (denoted the ABH antigens) and sialylated
Lewis antigens, respectively.32,33 The ABH antigens are also
expressed along the oro-gastrointestinal mucosal lining in
individuals of positive secretor status.34 A majority of Caucasians
(80%) are secretors, whereas 20% are non-secretors. Although we
did not determine the secretor status of the cohort analyzed in this
study, Argentina is considered to be a predominantly white
country. A recent study on the average genome of the Argentine
population established that it contains 79.9% of Caucasian race
contribution.35 We hypothesized that the high prevalence of less
severe pathologies, such as chronic gastritis and duodenitis, and
low rates of gastric cancer and PU diseases in our population, may
be associated with the prevalence of secretor phenotype, which
reduces bacterial density and the associated inﬂammation during
H. pylori infections.
In this study, a statistically signiﬁcant association between the
virulent cagA-positive/vacA s1m1/iceA1 genotypes was observed
(p = 0.0000). The rates of triple- and double-combined positive
were 14.7% and 31.8%, respectively. The triple-combined positive
rate was lower than that obtained in a previous study in eastern
Argentina (35.2%)9 and other Latin-American countries, with 32.6%
of cagA-positive/vacA s1m1/bab-positive genotype in Brazilian
patients23 and 56.2% in Cuban isolates.24 Despite the low rates
obtained in this work, there was a strong association between
combined virulent genotypes and PU (p = 0.0001) (Table 1).
Infection with these strains has been associated with a higher
degree of inﬂammation and gastro-duodenal lesions. The same
association has been observed between triple-virulent strains and
PU in several reports.6,12,24 The results obtained in this work
showed that the majority of double- (69/95) and all triple-virulent
strains have contact-dependent mechanisms to interact with
modiﬁed epithelial cells, including a type IV secretion system that
injects the virulence factors CagA into host cells.36 Recent reports
indicate that the translocation of CagA protein increases the risk of
gastric diseases because it plays a key role in altering epithelial cell
polarity to enable adhered H. pylori to turn the apical cell surface
into a replicative niche.36 It may be considered that Cag status
alone is not enough to induce gastric pathology in our population,but when it is combined with other virulence genes it is clearly
associated with PU.
The rate of ClaR obtained in this work (27.7%) is similar to that
of previous studies carried out in the same region of Argentina
(23.9%),37 Chile (20%),38 and Spain (21.4%),39 but higher than
Paraguay (2%).40 There are no previous reports ofH. pylori resistant
to Mtz in Argentina. The rate of MtzR was found to be 37.8% in this
work, in agreement with rates observed in developing countries,
which range between 5% and 90%, and higher than in Western
Europe and the USA.41
The correlation between virulence factors and antimicrobial
resistance varies in different countries. Most studies have shown
no signiﬁcant correlation,12 while in others, lower rates of
resistance to Cla and Mtz have been reported in more virulent
strains of H. pylori.42 However, in studies carried out in North
Wales and in Central Italy, a clear association has been found
between more virulent genotypes and antibiotic resistance.13,19 A
similar association has been observed between ClaR H. pylori
strains and iceA1 in western Argentina.37 In the present study, a
signiﬁcant association was found between combined virulence
markers, PU outcome, and resistance to Cla and Mtz, suggesting
that virulent strains are difﬁcult to eradicate in this region.
Moreover, it was found that a less virulent genotype cagA-
negative/vacA s2m2 was associated with susceptible isolates.
It has been reported that the efﬁcacy of triple therapy treatment
eradication of H. pylori, based on a per-protocol analysis, is
comparable among peptic ulcer and non-ulcer dyspepsia patients,
regardless of CagA status.43 It is well accepted that antibiotic
resistance is a leading cause of eradication treatment failure, so
tailored treatment based on antibiotic susceptibility testing might
be more effective in the achievement of a high eradication rate
when high resistances rates to Mtz or Cla are present in PU strains.
Also, another cause that would affect the efﬁcacy of eradication
treatment is the increased free and long-term use of PPIs in
Argentina to manage acid-related diseases usually associated with
the alimentary habits of the population (e.g., intake of 70 kg of red
meat per capita/year), which require digestive juices high in
hydrochloric acid. PPIs may induce aberrant forms and changes in
theH. pylori orientation in the epithelial cells that negatively affect
antimicrobial eradication treatment.44
Another factor to consider is that the hepaticmetabolism of PPIs
inﬂuences their inhibitory potency on hydrochloric acid secretion.
RAPD and rep-PCR techniques have shown a high discrimina-
tory power. However, few studies have suggested that DNA
ﬁngerprints may be useful in deﬁning disease-associated strains.15
H. pylori strains from ulcer patients have been found to be more
homogeneous as determined by PCR ﬁngerprints.45 Similarly, both
AO2 and BOX A1R ﬁngerprint patterns clearly deﬁned a distinct
pathological cluster for PU that segregated with combined
virulence markers and ClaR and MtzR strains. Both AO2 and
AO3 primers allowed the differentiation of ClaR and MtzR from
ClaS and MtzS strains, while the ERIC primer allowed the
segregation of virulence ﬁngerprints, but no disease-associated
strains. This is the ﬁrst report where BOX A1R primer has
successfully been used to discriminate H. pylori strains associated
with PU in Argentina.
Rep and RAPD primers were capable of generating DNA
ﬁngerprints, whichmay include virulence-speciﬁc or antimicrobial
resistance areas, and were useful in discriminating PU-related
strains. Also, H. pylori isolates from western Argentina that
harbored two or three virulence markers were more resistant to
antibiotic treatment. This association appears to be uncommon
and our ﬁnding is of special importance due to its implications for
the treatment and evolution of the pathology.
Combined analysis of the H. pylori virulent genotypes and
resistance patterns may permit identiﬁcation of high-risk
A.E. Vega et al. / International Journal of Infectious Diseases 14S (2010) e85–e92e92patients, to prevent PU later in life or to avoid antimicrobial
treatment failure.
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